MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

RESEARCH ARTICLE

Received: 13 Aug 2024

Revised: 27 Aug 2024

Accepted: 01 Sep 2024

*Corresponding author's e-mail: drgeethaprincy@gmail.com

Synthesis and characterization of insulin-loaded nanoparticles

fortified milk

P.Geetha*1 and M.Esther Magdalene Sharon2

Assistant Professor, 1Department of Food Processing Technology,

Assistant Professor, 2Dairy Chemistry,

College of Food and Dairy Technology,

Tamil Nadu Veterinary and Animal Sciences University, Chennai-600052,

ABSTRACT

Type 1 diabetes caused by the destruction of the pancreatic cells, leads

to reduced or no production of insulin, the hormone responsible for lowering

blood glucose levels. Insulin is a protein administered subcutaneously to

humans for treating, type I diabetes mellitus to control glucose homeostasis

when pancreatic β-cells production is not sufficient to ensure daily needs of

this hormone. The desire for a more convenient and socially compatible route

of insulin administration other than subcutaneous injection has originated

several approaches to attempt its oral delivery. The aim of this project is

to research and obtain a therapeutic food product containing an oral

insulin delivery system. The method used to synthesize the insulin loaded

nanoparticles is a two step Ionic pre-gelation method for the preparation

of alginate/chitosan nanoparticles. The sizes of the alginate-chitosan

nanoparticles were estimated by Scanning Electron Microcopy to range from

326-850nm. The characterization of the synthesized nanoparticles was

done using Scanning electron microsopy (SEM), Fourier Transform Infrared

spectroscopy (FTIR) and X-Ray Diffraction (XRD) studies. The interaction

between the Alginate and Chitosan was confirmed by the FTIR studies. From

the results of the XRD studies, it was observed that there was a decline in

the crystal structure of the Chitosan after the formation of the nanoparticles.

These Nanoparticles were homogenized with Ultra High Temperature (UHT)

sterilized milk containing 4.5% fat. The standard milk (control) and the milk

containing nanoparticles (product) was subjected to sensory analysis for the

color, aroma and consistency. From the sensory analysis of color, aroma and

consistency, it was found that there was no significant difference between

the control and the product.

Keywords: Alginate, Chitosan, Insulin, Therapeutic Milk, Oral Delivery System

INTRODUCTION

Diabetes is referred to a collection of disorders

defined by elevated blood glucose levels. The condition

arises from an insufficiency in insulin synthesis or

activity, or both, due to various factors, leading to

metabolic abnormalities of proteins and lipids. The

prolonged consequences of hypoglycemia include

harm to tissues and organs. Individuals with type 1

diabetes are incapable of producing sufficient insulin.

This category accounts for around 5%–10% of all

diabetes cases. This type involves the cellular death

of beta cells in the pancreas. In type 1 diabetes, the

pancreas fails to secrete insulin. Insulin is delivered

via subcutaneous injection to manage individuals with

type 1 diabetes (Mobasseri et al., 2020).

In addition to the psychological barriers for the use

of insulin in injectable form, its use is accompanied

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

by different complications such as hypoglycemia,

lipoatrophy at the injection site and all other risks

associated with injections. These complications make

the search into alternative routes for insulin delivery

is necessity. The other most studied routes are oral,

nasal, buccal and pulmonary. Buccal route is based

on the micellar solublisation. Nasal route was fully

investigated but no commercial exploitation is taking

place. Pulmonary route was commercially exploited

but unfortunately was withdrawn from the market.

Nevertheless, oral route is the most desired and has

been investigated thoroughly (Elsayed et al., 2011).

Oral delivery system is the preferred route for

administration because it is non-invasive, avoids

injections and decreases the risk of infections. It is also

physiologically desirable since the exogenous protein

imitates the physiological pathway undergoing first

hepatic bypass. The intestinal absorption of proteins

has been reported in a combination of mechanisms

described to explain how the protein cross the intestinal

mucosa (Sarmento et al., 2007). Peptide and protein

drugs are intrinsically poorly absorbable through the

intestinal membrane owing to high molecular weight

and hydrophilicity. Moreover, they are highly susceptible

for enzymatic degradation in the gastrointestinal

(GI) tract after oral administration. Entrapment of

peptides drugs in micro- and nanoparticulate carriers

protects them against the harsh environment of the

GI tract until they are absorbed in released or intact

particular form. In addition, formulations of the carrier

system using mucoadhesive polymers prolongs the

direct contact of the particles to the mucosal surface,

achieves higher local drug concentration in the mucus

layer, and minimizes drug dilution and degradation by

the luminal content (Li et al., 2008).

Nanoparticles

consisting

of

synthetic

biodegradable polymers, natural biopolymers, lipids

and polysaccharides have been developed and tested

over the past decades. Recently, the idea of using

nanoparticles made from natural biodegradable

polymers to deliver drugs has provoked great

interests. Among them, alginate and chitosan are

very promising and have been widely exploited in

pharmaceutical industry for controlling drug release

(Makhlof et al., 2011). Sodium Alginate has a unique

property of cross linking in the presence of multivalent

cations such as calcium ions in aqueous media.

Alginate forms a reticulated structure in contact with

calcium ions and this network can entrap proteins.

Chitosan is a linear copolymer polysaccharide and it

is produced commercially by deacetylation of chitin,

which is the structural element in the exoskeleton of

the crustaceans. The strong electrostatic interaction of

the amino groups of the chitosan with the carboxylic

groups of the alginate leads to the formation of

the complex chitosan/alginate that becomes the

polyelectrolyte complex between chitosan and alginate

has been widely used in order to obtain microcapsules

for cell encapsulation and devices for the controlled

release of drugs or other substances (Finotelli et al.,

2010).

There is a growing awareness nowadays of

the health benefits of a category of bioactive food

constituents known as nutraceuticals. This has

created society demand for products (functional

foods) and preparations rich in these constituents

to improve public health. It is well documented that

their consumption produces physiological benefits or

reduce the long-term risk of developing degenerative

diseases. On the other hand, the added bioactive

constituents may have some undesirable effects on

the taste and odour of the food matrix used as many of

these constituents have undesirable taste and odour.

Therefore, the objectives of food manufacturers and

nutritionists have been to maximize the availability of

administered nutraceuticals without compromising

consumer acceptability (Salam et al., 2012). This

study aims to develop functional dairy food (milk) with

oral insulin delivery system to overcome the limitations

of the painful subcutaneous injections of insulin

administration and produce a more patient friendly

method of insulin administration. It involves the

synthesis, characterization and mixing of the insulin

loaded nanoparticles into milk and observation of the

settling and dispersion in it.

MATERIAL AND METHODS

Materials

Sodium alginate, chitosan and calcium chloride were

purchased from Himedia Laboratories. Recombinant

human isophane insulin was purchased under the

brand name of Humulin N®from Biocon Laboratory,

India. Milk used in this study was purchased from the

local market. UHT sterilized standard milk (4.5% fat)

which was marketed by Amul Dairy under the Brand

name of Amul Gold was used in this study. Deioinzed

water (Milli-Q®) was used throughout the process as a

medium.

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Preparation of Nanoparticles

Insulin loaded Alginate-Chitosan Nanoparticles

were produced by dilute alginate solutions containing

insulin by inducing an ionotropic pre-gel with calcium

counter ions followed by polyelectrolyte complex

coating with Chitosan as described by Sarmento et al,

2007). with isophane insulin as source of insulin.

Nanoparticle Characterization

The prepared nanoparticles were characterized

using scanning electron microscopy, Fourier transform

infrared spectroscopy and x-ray diffraction studies.

The morphology such as the shape, size and the

occurrence of aggregation of particles were studied by

scanning electron microscopy. The interaction between

the various components of the nanoparticulate

systems were studied using Fouriertransform infrared

spectroscopy. The crystalline nature of the components

of the nanoparticles namely, the alginate and the

chitosan were studied using x-ray diffraction studies

before and after the formation of the nanoparticles.

Scanning Electron Microscopy

Scanning electron microscopy was done using a low

vacuum FEI QuantaFEGSEM (5kV) at 80 Torr. Alginate

chitosan nanoparticles were synthesized with three

different concentrations of chitosan. This synthesis

was carried out and the influence of the chitosan

concentration on the size of the nanoparticles formed

was studied using scanning electron microscopy. The

lyophilized nanoparticles powders were mounted on

a stub using a carbon tape and then examined for

the shape, size and the aggregation nature of the

nanoparticles.

Fourier Transform Infrared Spectroscopy

FTIR spectra were measured using a Bruker-α

spectrometer. The samples were gently mixed with

micronized KBr powder and compressed into discs

at a force of 10 kN for 1 minute using a manual

tablet presser. The interferogram was collected in

absorption from 400 cm-1 and 4000cm-1 region at

room temperature.

X-Ray Diffraction

X-Ray diffraction of the lyophilized powder samples

was done using PANalyticalXpert Pro XRD in powder

mode. The scanning was done at the rate of 0.05°/

step and 2 sec/step with CuKα as the source of x-ray

with a wavelength of 0.154 nm. The powdered samples

of chitosan, alginate, alginate/chitosan nanoparticles

and insulin loaded alginate/chitosan nanoparticles

were analysed for the crystalline nature.

Association Efficiency (AE)

The association efficiency of the insulin to the

nanoparticles was analysed to find out the amount

of insulin bound to the nanoparticles. The insulin

determinations were done in triplicates. It was

calculated using the following formula:

In-Vitro Insulin Release Studies

The insulin release profile from nanoparticles

in simulated gastric and intestinal pH was carried

out to study the amount of insulin released from

the nanoparticles in to the medium simulating the

stomach and intestinal conditions. The nanoparticles

were placed into test tubes containing 20 mL of HCl

buffer pH 1.5 or PBS buffer pH 7.4. At appropriate

intervals of 30 minutes, aliquots of 500 µL were

taken and replaced by fresh buffer. Aliquots were

centrifuged at 5000g for 15 minutes. The amount of

insulin released from the nanoparticles was evaluated

by HPLC.

Incorporation of nanoparticles into milk

The lyophilized nanoparticles in the form of

powders were added to UHT pasteurized milk. The

total yield of powders from a single batch of prepared

nanoparticles was added to 100 mLmLof UHT

pasteurized milk using a blender. The milk containing

the insulin loaded nanoparticles was kept at 4°C. The

addition of the nanoparticles was done under sterile

conditions to prevent the spoilage of the product.

Sensory analysis

The standard milk and the milk containing insulin

loaded nanoparticles were evaluated for acceptability

by a panel of judges for aroma, color and appearance,

consistency according to 9-point hedonic scale

wherein a score of 1 represented dislike extremely

and score of 9 represented like extremely.

RESULTS AND DISCUSSION

Synthesis and characterization of Insulin loaded

nanoparticles by Spontaneous Emulsification

Solvent Diffusion Method

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Chitosan solutions at concentrations of 0.05%,

0.07%, and 0.09% were prepared for analysis, with

the dimensions and characteristics of the resulting

nanoparticles detailed in Table 1. Each experiment

was conducted in triplicate.

Scanning electron micrographs revealed that

the synthesis process using the lowest chitosan

concentration

(0.05%)

produced

cylindrical

nanofibers, as shown in Figure 1. Table 2 presents the

variance analysis for nanoparticle sizes at chitosan

concentrations of 0.07% and 0.09%, indicating that

the size reduction between these concentrations

was

statistically

insignificant.

The

scanning

electron micrographs of the nanoparticles produced

from the three chitosan concentrations—0.05%,

0.07%, and 0.09%—are shown in Figures 1, 2, and 3,

respectively.

The size of the nanoparticles was measured

to be 68.4±2.800 nm and 66.7±1.201 nm when

synthesizing nanoparticles with starting chitosan

concentrations of 0.07% and 0.09%, respectively.

Particles of a size smaller than 100 nm shown a 2.5-

fold increase in uptake compared to microparticles

measuring 1µm (Panyam and Labhasetwar, 2003).

Preliminary attention was given to polyelectrolyte

interactions and insulin trapping in order to

investigate the linkages between components of the

nanoparticulate systems. The interaction between

the carboxyl (-COO-) group of the anionic polymer

and the amino group (-NH3+) of chitosan is a known

phenomenon. This interaction leads to the formation

of an ionic complex between the two molecules, as

described by Sarmento et al, 2006).

Fourier Transform Infrared (FTIR) spectroscopy

The synthesis of insulin-loaded nanoparticles

was carried out, and the interactions between the

nanoparticle constituents, specifically chitosan and

alginate, were analyzed using Fourier Transform

Infrared (FTIR) spectroscopy. Figure 4 shows the FTIR

spectrum of pure chitosan, which was examined to

identify the highest values within the ranges of 3000–

3120 cm¹, 1480–1530 cm¹, and 1590–1620 cm¹.

These peaks correspond to the presence of amino

groups (-NH₃⁺) in the spectrum. The observed peaks in

Figure 4 confirm the presence of amino groups (-NH₃⁺)

in pure chitosan at wavenumbers of 1501.72 cm¹,

1654.73 cm¹, 3045.94 cm¹, 3079.94 cm¹, and

3147.95 cm¹.

The highest point within the range of 1710 cm-1

– 1740 cm-1 indicates the existence of saturated

carboxylic acids. Figure 5 displays a prominent signal

at 1738.31 cm-1, indicating the existence of the

carboxylic group in the alginate solution employed for

nanoparticle production.

Table 1.The initial concentration of chitosan, size and nature of the nanoparticles

S.No.

Chitosan Concentration%

( w/v)

Size (in nm)

Nature

1

0.05

--

Nanofibres like structures

2

0.07

68.4±2.800

Agglomerated

3

0.09

66.7±1.201

Agglomerated

Table 2 Peak Values of FTIR spectrum of Alginate, Chitosan, and Nanoparticles formed with initial

chitosan concentrations of 0.05%, 0.07%, and 0.09%.

Samples

Alginate (COO-) &

Chitosan (NH3

+)

Initial Concentration of Chitosan

Functional groups

0.05%

0.07%

0.09%

COO--

1738.31

1738.49

1732.83

1742.75

NH3

+

1501.72

1517.46

1525.96

1514.23

1654.73

1640.73

1606.73

1646.40

3045.94

3284.30

3355.14

2920.16

3079.94

3315.47

3386.31

2952.75

3147.95

3348.05

3416.06

3455.74

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Fig 2. Scanning Electron Micrographs of nanoparticles with initial chitosan concentration of 0.07%

The size of the nanoparticles was measured to be 68.4±2.800 nm and 66.7±1.201 nm when

synthesizing nanoparticles with starting chitosan concentrations of 0.07% and 0.09%, respectively.

Particles of a size smaller than 100 nm shown a 2.5-fold increase in uptake compared to microparticles

measuring 1µm (Panyam and Labhasetwar, 2003).

Fig 3. Scanning Electron Micrographs of Nanoparticles synthesized with initial chitosan concentration of

0.09%

Preliminary attention was given to polyelectrolyte interactions and insulin trapping in order to investigate

the linkages between components of the nanoparticulate systems. The interaction between the carboxyl (-

COO-) group of the anionic polymer and the amino group (-NH3+) of chitosan is a known phenomenon. This

interaction leads to the formation of an ionic complex between the two molecules, as described by

Sarmento et al, 2006).

Fourier Transform Infrared (FTIR) spectroscopy

The synthesis of insulin loaded nanoparticles was carried out and the interactions between the

Fig 3. Scanning Electron Micrographs of Nanoparticles synthesized with initial chitosan

concentration of 0.09%

Volume 111 | Issue 7-9 |

Scanning electron micrographs revealed that the synthesis process using the lowest chitosan

concentration (0.05%) produced cylindrical nanofibers, as shown in Figure 1. Table 2 presents the variance

analysis for nanoparticle sizes at chitosan concentrations of 0.07% and 0.09%, indicating that the size

reduction between these concentrations was statistically insignificant. The scanning electron micrographs

of the nanoparticles produced from the three chitosan concentrations0.05%, 0.07%, and 0.09%are

shown in Figures 1, 2, and 3, respectively.

Fig 1.Scanning Electron Micrographs of nanofibre-like structures formed with initial Chitosan Concentration

of 0.05%

Fig 2. Scanning Electron Micrographs of nanoparticles with initial chitosan concentration of 0.07%

Volume 111 | Issue 7-9 |

(

) p

y

,

g

p

analysis for nanoparticle sizes at chitosan concentrations of 0.07% and 0.09%, indicating that the size

reduction between these concentrations was statistically insignificant. The scanning electron micrographs

of the nanoparticles produced from the three chitosan concentrations0.05%, 0.07%, and 0.09%are

shown in Figures 1, 2, and 3, respectively.

Fig 1.Scanning Electron Micrographs of nanofibre-like structures formed with initial Chitosan Concentration

of 0.05%

An analysis was conducted on nanoparticles

synthesized

using

chitosan

concentrations

of

0.05%, 0.07%, and 0.09% to examine the presence

of amino and carboxyl groups in their respective

FTIR spectra. Figure 6 displays the FTIR spectra of

alginate, chitosan, and nanoparticles prepared with

chitosan concentrations of 0.05%, 0.07%, and 0.09%,

respectively. The peak values for chitosan, alginate,

and the nanoparticles synthesized with initial chitosan

concentrations of 0.05%, 0.07%, and 0.09% are

presented in Table 2. Each spectrum was individually

analyzed to identify any shifts in the peak values of

the amino and carboxyl groups, which would suggest

interactions between chitosan and alginate in the

nanoparticulate systems.

Fig 1.Scanning Electron Micrographs of nanofibre-like structures formed with initial Chitosan

Concentration of 0.05%

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Fig 4. FTIR spectrum of Chitosan

The highest point within the range of 1710 cm-1 1740 cm-1 indicates the existence of saturated

carboxylic acids. Figure 5 displays a prominent signal at 1738.31 cm-1, indicating the existence of the

carboxylic group in the alginate solution employed for nanoparticle production.

Figure 5 FTIR spectrum of alginate

An analysis was conducted on nanoparticles synthesized using chitosan concentrations of 0.05%, 0.07%,

and 0.09% to examine the presence of amino and carboxyl groups in their respective FTIR spectra. Figure

6 displays the FTIR spectra of alginate, chitosan, and nanoparticles prepared with chitosan concentrations

of 0.05%, 0.07%, and 0.09%, respectively. The peak values for chitosan, alginate, and the nanoparticles

synthesized with initial chitosan concentrations of 0.05%, 0.07%, and 0.09% are presented in Table 2.

Each spectrum was individually analyzed to identify any shifts in the peak values of the amino and carboxyl

groups, which would suggest interactions between chitosan and alginate in the nanoparticulate systems.

The analysis revealed a slight shift in the peak values of the carboxyl group. Specifically, the peak

shifted from 1738.31 cm¹ in alginate to 1738.49 cm¹ in nanoparticles with an initial chitosan

concentration of 0.05%. Additionally, there was a shift in the peak values of the amino groups, moving from

1501.72 cm¹.

The wavenumber range for chitosan was observed between 1654.73 cm¹ and 3147.95 cm¹,

while for nanoparticles synthesized with a chitosan concentration of 0.05%, the range extended from

1517.46 cm¹ to 3348.05 cm¹.

Volume 111 | Issue 7-9 |

Infrared (FTIR) spectroscopy. Figure 4 shows the FTIR spectrum of pure chitosan, which was examined to

identify the highest values within the ranges of 30003120 cm¹, 14801530 cm¹, and 15901620

cm¹. These peaks correspond to the presence of amino groups (-NH₃⁺) in the spectrum. The observed

peaks in Figure 4 confirm the presence of amino groups (-NH₃⁺) in pure chitosan at wavenumbers of

1501.72 cm¹, 1654.73 cm¹, 3045.94 cm¹, 3079.94 cm¹, and 3147.95 cm¹.

Fig. 5 FTIR spectrum of alginate

The analysis revealed a slight shift in the peak

values of the carboxyl group. Specifically, the peak

shifted from 1738.31 cm¹ in alginate to 1738.49 cm¹

in nanoparticles with an initial chitosan concentration

of 0.05%. Additionally, there was a shift in the peak

values of the amino groups, moving from 1501.72

cm¹.

The wavenumber range for chitosan was observed

between 1654.73 cm¹ and 3147.95 cm¹, while

for nanoparticles synthesized with a chitosan

concentration of 0.05%, the range extended from

1517.46 cm¹ to 3348.05 cm¹.

The spectra indicate a shift in the peak values

of the carboxyl group, moving from 1738.31 cm¹ in

alginate to 1732.38 cm¹ in nanoparticles with an

initial chitosan concentration of 0.05%. Similarly,

shifts are observed in the peak values of the amino

groups, which change from 1501.72 cm¹, 1654.73

cm¹, 3045.94 cm¹, 3079.94 cm¹, and 3147.95

cm¹ in chitosan to 1525.96 cm¹, 1606.73 cm¹,

3355.14 cm¹, 3386.47 cm¹, and 3416.06 cm¹ in

nanoparticles formed with a chitosan concentration of

0.07%.

For nanoparticles prepared with an initial chitosan

concentration of 0.09%, the carboxyl group peak

shifted from 1738.31 cm¹ in alginate to 1742.75

cm¹ in the nanoparticles. The amino group peaks

also displayed changes, moving from 1501.72 cm¹,

1654.73 cm¹, 3045.94 cm¹, 3079.94 cm¹, and

3147.95 cm¹ in chitosan to 1514.23 cm¹, 1646.40

cm¹, 2920.16 cm¹, 2952.75 cm¹, and 3455.74

cm¹ in the nanoparticles, respectively.

The results of the study indicate that the shifts in the

peaks representing the amino group and the carboxyl

groups in the FTIR spectrum of the nanoparticles

provide evidence of the interaction between the

carboxyl (-COO-) group of the anionic polymer and the

amino group (-NH3+) of Chitosan. This interaction

leads to the formation of an ionic complex between

the two compounds in the nanoparticulate system.

X-ray diffraction (XRD) studies

The nanoparticles containing Humulin N, along

with

the

nanoparticulate

system

components,

chitosan and alginate, were analyzed using X-ray

diffraction (XRD) to assess any

Fig 4. FTIR spectrum of Chitosan

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Volume 111 | Issue 7-9 |

carboxylic group in the alginate solution employed for nanoparticle production.

Figure 5 FTIR spectrum of alginate

An analysis was conducted on nanoparticles synthesized using chitosan concentrations of 0.05%, 0.07%,

and 0.09% to examine the presence of amino and carboxyl groups in their respective FTIR spectra. Figure

6 displays the FTIR spectra of alginate, chitosan, and nanoparticles prepared with chitosan concentrations

of 0.05%, 0.07%, and 0.09%, respectively. The peak values for chitosan, alginate, and the nanoparticles

synthesized with initial chitosan concentrations of 0.05%, 0.07%, and 0.09% are presented in Table 2.

Each spectrum was individually analyzed to identify any shifts in the peak values of the amino and carboxyl

groups, which would suggest interactions between chitosan and alginate in the nanoparticulate systems.

The analysis revealed a slight shift in the peak values of the carboxyl group. Specifically, the peak

shifted from 1738.31 cm¹ in alginate to 1738.49 cm¹ in nanoparticles with an initial chitosan

concentration of 0.05%. Additionally, there was a shift in the peak values of the amino groups, moving from

1501.72 cm¹.

The wavenumber range for chitosan was observed between 1654.73 cm¹ and 3147.95 cm¹,

while for nanoparticles synthesized with a chitosan concentration of 0.05%, the range extended from

1517.46 cm¹ to 3348.05 cm¹.

Fig 6. FTIR spectrum of Chitosan (blue), Alginate (red), and Nanoparticles with initial chitosan

concentration of 0.05% (green), 0.07% (orange), and 0.09% (violet)

The spectra indicate a shift in the peak values of the carboxyl group, moving from 1738.31 cm¹ in alginate

to 1732.38 cm¹ in nanoparticles with an initial chitosan concentration of 0.05%. Similarly, shifts are

observed in the peak values of the amino groups, which change from 1501.72 cm¹, 1654.73 cm¹,

3045.94 cm¹, 3079.94 cm¹, and 3147.95 cm¹ in chitosan to 1525.96 cm¹, 1606.73 cm¹, 3355.14

cm¹, 3386.47 cm¹, and 3416.06 cm¹ in nanoparticles formed with a chitosan concentration of 0.07%.

For nanoparticles prepared with an initial chitosan concentration of 0.09%, the carboxyl group peak shifted

from 1738.31 cm¹ in alginate to 1742.75 cm¹ in the nanoparticles. The amino group peaks also

displayed changes, moving from 1501.72 cm¹, 1654.73 cm¹, 3045.94 cm¹, 3079.94 cm¹, and

3147.95 cm¹ in chitosan to 1514.23 cm¹, 1646.40 cm¹, 2920.16 cm¹, 2952.75 cm¹, and 3455.74

cm¹ in the nanoparticles, respectively.

The results of the study indicate that the shifts in the peaks representing the amino group and the

carboxyl groups in the FTIR spectrum of the nanoparticles provide evidence of the interaction between the

carboxyl (-COO-) group of the anionic polymer and the amino group (-NH3+) of Chitosan. This interaction

leads to the formation of an ionic complex between the two compounds in the nanoparticulate system.

X-ray diffraction (XRD) studies

The nanoparticles containing Humulin N, along with the nanoparticulate system components,

chitosan and alginate, were analyzed using X-ray diffraction (XRD) to assess any changes in the crystalline

structure of chitosan and alginate before and after nanoparticle formation. XRD analysis of the individual

components showed that chitosan exhibited a crystalline structure, while alginate appeared to be

amorphous. The crystalline nature of chitosan was evidenced by a prominent peak at 20.38° in its X-ray

diffractogram. In contrast, alginate's diffractogram displayed no distinct peaks, indicating its amorphous

nature. Figure 7 shows the X-ray diffractograms of chitosan and alginate before nanoparticle synthesis.

Fig 7. X-Ray Diffractogram of Alginate (red) and Chitosan (black) before the formation of nanoparticles

The X-ray diffraction pattern of nanoparticles created with an initial chitosan content of 0.05%.,

0.07% and 0.09%. represents the values of Figure 8. The diffractogram shows that a solitary significant

Table 3 Peak Values of FTIR spectra of Alginate, Chitosan and Nanoparticles with Humulin N

Samples

Alginate (COO-) &

Chitosan (NH3

+)

Nanoparticles with Humulin N

Functional groups

COO--

1738.31

1738.49

NH3

+

1501.72

1510.38

1654.73

1646.40

3045.94

2931.50

3079.94

2964.08

3147.95

3420.32

changes in the crystalline structure of chitosan and

alginate before and after nanoparticle formation.

XRD analysis of the individual components showed

that chitosan exhibited a crystalline structure,

while alginate appeared to be amorphous. The

crystalline nature of chitosan was evidenced by a

prominent peak at 20.38° in its X-ray diffractogram.

In contrast, alginate’s diffractogram displayed no

distinct peaks, indicating its amorphous nature.

Figure 7 shows the X-ray diffractograms of chitosan

and alginate before nanoparticle synthesis.

The X-ray diffraction pattern of nanoparticles

created with an initial chitosan content of 0.05%.,

0.07% and 0.09%. represents the values of Figure

8. The diffractogram shows that a solitary significant

peak of chitosan vanished following the creation of

the nanoparticles. All three nanoparticles have an

amorphous structure.

Thus, the decline in crystallinity of chitosan may

be caused due to interaction with alginate and other

components of the nanoparticulate system. The result

Fig 6. FTIR spectrum of Chitosan (blue), Alginate (red), and Nanoparticles with initial chitosan

concentration of 0.05% (green), 0.07% (orange), and 0.09% (violet)

Fig 7. X-Ray Diffractogram of Alginate (red) and Chitosan (black) before the formation of nanoparticles

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

obtained in the current study is in accordance with the

observations by Lin et al, 2007 where the disruption

of the crystal structure of the chitosan was observed

after chitosan combined with γ-PGA via electrostatic

interactions to form Chitosan-γ-PGA nanoparticles.

Synthesis and characterization of Insulin

loaded nanoparticles by Ionic Pregelation with

Polyelectrolyte complexation method

Scanning Electron Microscopy studies

Alginate chitosan nanoparticles were synthesized.

On slow addition of the chitosan over the pregel mixture

(formed by addition of CaCl2 over the alginate insulin

solution), the solution changed from clear to opalescent

and finally turning turbid indicating the formation of

the insulin loaded nanoparticles. This synthesis was

Fig 9. Scannniing Electron Micrographs of Insulin Loadded Nannoparticles

Volume 111 | Issue 7-9 |

peak of chitosan vanished following the creation of the nanoparticles. All three nanoparticles have an

amorphous structure.

Figure 8 X-Ray Diffractograms of Nanoparticles with initial chitosan concentration of 0.05% (Green), 0.07%

(Blue), and 0.09% (Red)

Thus, the decline in crystallinity of chitosan may be caused due to interaction with alginate and

other components of the nanoparticulate system. The result obtained in the current study is in accordance

with the observations by Lin et al, 2007 where the disruption of the crystal structure of the chitosan was

observed after chitosan combined with γ-PGA via electrostatic interactions to form Chitosan-γ-PGA

nanoparticles.

Synthesis and characterization of Inssulin loaded nanoparticles by Ionic Pregelation with

Polyelectrolytte complexation method

Scanning Electron Microscopy studies

Alginate chitosan nanoparticles were synthesized. On slow addition of the chitosan over the

pregel mixture (formed by addition of CaCl2 over the alginate insulin solution), the solution changed from

clear to opalescent and finally turning turbid indicating the formation of the insulin loaded nanoparticles.

This synthesis was carried out and the size of the nanoparticles formed was studied using scanning

electron microscopy. Isophane insulin (Humulin N®) suspension was taken as source of insulin for

synthesis. The sizes of the nanoparticles formed ranged between 326 nm 850 nm and the nanoparticles

were not regular spheres as observed from the scanning electron micrographs. The scanning electron

micrographs of the nanoparticles synthesized is represented in Figure 9. Particles below 1000 nm are

desirable as they are better absorbed in the intestinal tract.

carried out and the size of the nanoparticles formed

was studied using scanning electron microscopy.

Isophane insulin (Humulin N®) suspension was taken

as source of insulin for synthesis. The sizes of the

nanoparticles formed ranged between 326 nm – 850

nm and the nanoparticles were not regular spheres as

observed from the scanning electron micrographs. The

scanning electron micrographs of the nanoparticles

synthesized is represented in Figure 9. Particles below

1000 nm are desirable as they are better absorbed in

the intestinal tract.

Fourier Transform Infrared Spectroscopy (FTIR)

studies

The nanoparticles synthesized with Humulin N

as insulin sources were subjected to FTIR studies.

Figure 10 shows a combined representation of the

FTIR spectra of alginate, Chitosan and nanoparticles

synthesized with Humulin N. The peak values were

noted and investigated for the shift in the peak values

of amino group and the carboxyl group.

The peak values are displayed in the table 1. The

peak values of alginate and chitosan were subjected

to comparison with the peak values of nanoparticles

with Humulin N individually in order to ascertain

the interaction between the components of the

nanoparticulate systems.

The following observations were made from the

FTIR spectra of Humulin N as insulin source. There is a

presence of shifts in the peak values of amino groups

from 1501.72 cm-1, 1654.73 cm-1, 3045.94 cm-1 ,

3079.94 cm-1 and 3147.95 cm-1 in chitosan to 1510.38

Figure 8 X-Ray Diffractograms of Nanoparticles with initial chitosan concentration of 0.05%

(Green), 0.07% (Blue), and 0.09% (Red)

Fig 9. Scanning Electron Micrographs of

Insulin Loaded Nanoparticles

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Volume 111 | Issue 7-9 |

p

p

g

,

p

y

with Humulin N. The peak values were noted and investigated for the shift in the peak values of amino

group and the carboxyl group.

The peak values are displayed in the table 1. The peak values of alginate and chitosan were

subjected to comparison with the peak values of nanoparticles with Humulin N individually in order to

ascertain the interaction between the components of the nanoparticulate systems.

Fig 10. FTIR spectra of Alginate (red), Chitosan (blue), Nanoparticles with Humulin N (green)

The following observations were made from the FTIR spectra of Humulin N as insulin source. There

is a presence of shifts in the peak values of amino groups from 1501.72 cm-1, 1654.73 cm-1, 3045.94 cm-

1 , 3079.94 cm-1 and 3147.95 cm-1 in chitosan to 1510.38 cm-1, 1646.40 cm-1, 2931.30.66 cm-1,

2964.08 cm-1, 3420.32 cm-1 in nanoparticles with Humulin N as insulin source. The shift was also

observed in the carboxyl group peaks from 1738.31 cm-1 in alginate to 1738.49 cm-1 in the nanoparticles

with Humulin N.

From the results of the present study, it is evident that the shifts in the peaks representing the

amino group and the carboxyl groups in the FTIR spectrum of the nanoparticles confirms the interaction

between the the carboxyl (-COO-) group of the anionic polymer and the amino group (-NH3+) of chitosan to

form an ionic complex between the two compounds in the nanoparticulate system in the present study.

X-Ray Diffraction studies

Fig 11. X-Ray Diffractogram of Chitosan (red) , alginate (blue)and Nanoparticles with Humulin N (green)

The observations from the X-Ray Diffractogram of nanoparticles with H Humulin N shows the

decrease in the crystallinity of the Chitosan which is evident from the absence of a single clear peak at

20.38° in the X-Ray diffractogram with the intensity equal to that of the Chitosan before the formation of

the nanoparticles. The X-Ray diffractogram of chitosan, alginate and the nanoparticles with Humulin N is

shown in the figure 11.

Association Efficiency

The nanoparticles were analyzed for the amount of insulin associated with it after the synthesis. This study

was carried out by investigating the supernatant obtained after the centrifugation of the reaction mixture to

HPLC for the presence of insulin. Standard calibration curves for both types of insulin used in the study

were constructed by running known amounts of insulin (Humulin N) in the HPLC. The Standard

Chromatogram of the Humulin N are as shown in the figure 12. The peak at approximately 11 minutes

indicates presence and amount of insulin in the sample.

cm-1, 1646.40 cm-1, 2931.30.66 cm-1, 2964.08 cm-

1, 3420.32 cm-1 in nanoparticles with Humulin N as

insulin source. The shift was also observed in the

carboxyl group peaks from 1738.31 cm-1 in alginate

to 1738.49 cm-1 in the nanoparticles with Humulin N.

From the results of the present study, it is evident

that the shifts in the peaks representing the amino

group and the carboxyl groups in the FTIR spectrum

of the nanoparticles confirms the interaction between

the the carboxyl (-COO-) group of the anionic polymer

and the amino group (-NH3

+) of chitosan to form an

ionic complex between the two compounds in the

nanoparticulate system in the present study.

X-Ray Diffraction studies

The observations from the X-Ray Diffractogram of

nanoparticles with H Humulin N shows the decrease in

the crystallinity of the Chitosan which is evident from

the absence of a single clear peak at 20.38° in the

X-Ray diffractogram with the intensity equal to that of

the Chitosan before the formation of the nanoparticles.

The X-Ray diffractogram of chitosan, alginate and the

nanoparticles with Humulin N is shown in the figure

11.

Association Efficiency

The nanoparticles were analyzed for the amount

of insulin associated with it after the synthesis. This

study was carried out by investigating the supernatant

obtained after the centrifugation of the reaction

mixture to HPLC for the presence of insulin. Standard

calibration curves for both types of insulin used in the

study were constructed by running known amounts

of insulin (Humulin N) in the HPLC. The Standard

Chromatogram of the Humulin N are as shown in

the figure 12. The peak at approximately 11 minutes

indicates presence and amount of insulin in the

sample.

Fig 10. FTIR spectra of Alginate (red), Chitosan (blue), Nanoparticles with Humulin N (green)

Fig 11. X-Ray Diffractogram of Chitosan (red) , alginate (blue)and Nanoparticles with Humulin N

(green)

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Volume 111 | Issue 7-9 |

Fig 11. X-Ray Diffractogram of Chitosan (red) , alginate (blue)and Nanoparticles with Humulin N (green)

The observations from the X-Ray Diffractogram of nanoparticles with H Humulin N shows the

decrease in the crystallinity of the Chitosan which is evident from the absence of a single clear peak at

20.38° in the X-Ray diffractogram with the intensity equal to that of the Chitosan before the formation of

the nanoparticles. The X-Ray diffractogram of chitosan, alginate and the nanoparticles with Humulin N is

shown in the figure 11.

Association Efficiency

The nanoparticles were analyzed for the amount of insulin associated with it after the synthesis. This study

was carried out by investigating the supernatant obtained after the centrifugation of the reaction mixture to

HPLC for the presence of insulin. Standard calibration curves for both types of insulin used in the study

were constructed by running known amounts of insulin (Humulin N) in the HPLC. The Standard

Chromatogram of the Humulin N are as shown in the figure 12. The peak at approximately 11 minutes

indicates presence and amount of insulin in the sample.

Fig 12. Chromatogram of standard Humulin N

In the above chromatograms, a peak at approximately 6 minutes is observed. This presence of this peak

may not be considered as there is a similar peak observed when deionised water was run in the same

column with the same linear gradient program as followed for analysis of standards and the sample .Figure

13 displays the standard calibration curve of Humulin n. The efficiency of the insulin's association with the

nanoparticles was determined to be 55.3±3.066 (%)

Fig. 13 Staandard Calibration curve of Humulin N in HPLC.

Invitro Insulin Release Studies

In the above chromatograms, a peak at

approximately 6 minutes is observed. This presence

of this peak may not be considered as there is a

similar peak observed when deionised water was run

in the same column with the same linear gradient

program as followed for analysis of standards and the

sample .Figure 13 displays the standard calibration

curve of Humulin n. The efficiency of the insulin’s

association with the nanoparticles was determined to

be 55.3±3.066 (%)

Invitro Insulin Release Studies

The amount of insulin released in the simulated

gastric fluid and simulated intestinal fluid is as shown

in the Figure 14. It is observed that 34.7% of the

associated insulin was released in the simulated

Gastric fluid and that 77.27% of the associated insulin

was released in the simulated intestinal fluid.

In the first two hours of the study, a burst release

pattern was observed, where a significant amount of

insulin was rapidly released from the nanoparticles into

both simulated gastric and intestinal fluids. This initial

release likely stems from weak interactions between

insulin and the nanoparticle surfaces, as the alginate

core may lack sufficient strength to fully retain the

insulin. Approximately 30% of the insulin maintained

a stable interaction with the nanoparticles even after

2 hours in the release media. Comparatively, the type

of insulin used for encapsulation did not significantly

affect the release pattern, aligning with findings by

Sarmento et al., 2006b. The standard chromatogram

of the in vitro insulin release study is shown in Figure

15

A distinct peak at approximately 11 minutes

suggests the presence of insulin without detectable

Fig 12. Chromatogram of standard Humulin N

Fig. 13 Standard Calibration curve of Humulin N in HPLC.

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

In the first two hours of the study, a burst release pattern was observed, where a significant amount of

insulin was rapidly released from the nanoparticles into both simulated gastric and intestinal fluids. This

initial release likely stems from weak interactions between insulin and the nanoparticle surfaces, as the

alginate core may lack sufficient strength to fully retain the insulin. Approximately 30% of the insulin

maintained a stable interaction with the nanoparticles even after 2 hours in the release media.

Comparatively, the type of insulin used for encapsulation did not significantly affect the release pattern,

aligning with findings by Sarmento et al., 2006b. The standard chromatogram of the in vitro insulin release

study is shown in Figure 15

Figure 15 Chromatogram of Humulin N in simulated intestinal fluid

A distinct peak at approximately 11 minutes suggests the presence of insulin without detectable hydrolysis

hydrolysis degradation products. This aligns with

findings by Sarmento et al. (2006b), indicating that

nanoparticulate carriers can preserve the primary

structure of insulin during encapsulation. Therefore,

changing the type of insulin as the core material has

minimal impact on the coating material’s ability to

retain insulin’s primary structure.

Nanoparticle incorporated into milk

The insulin loaded nanoparticles which were

investigated for their release characteristics were

synthesized again and were lyophilized. The lyophilized

nanoparticles were then added to 4.5% fat standard

milk and mixed thoroughly for few seconds using a

blender. There were no settling or sedimentation of the

nanoparticles in the milk. The milk containing Insulin

loaded nanoparticles are as shown in the figure 16.

In order to study if there are any differences in

the physical properties of the control (milk without

nanoparticles) and the product (milk containing the

insulin loaded nanoparticles), a sensory analysis of

appearance (whiteness), aroma and the consistency

was conducted on a 9 point hedonic scale from 20

panel members . The results of the sensory analyses

of appearance, aroma and consistency are as

represented in figure 17.

The nutritional profiles of the milk without and

with the nanoparticles are as shown in Figure18

and Figure 19 respectively. From the results of the

nutritional analysis studies, it was observed that

there is no significant difference in the total fat, ash

and moisture content between the control and the

product. A difference of 0.2g in protein per 100 mL of

milk was observed. The product showed 0.2 g increase

in protein compared to the control.

This may be due to the release of insulin which are

held on the surfaces of the coating material by weak

interactions. Further investigations are needed to be

made in the development of a method for estimating

the presence and the amount of insulin present in the

milk samples.

Volume 111 | Issue 7-9 |

Invitro Insulin Release Studies

The amount of insulin released in the simulated gastric fluid and simulated intestinal fluid is as shown in

the Figure 14. It is observed that 34.7% of the associated insulin was released in the simulated Gastric

fluid and that 77.27% of the associated insulin was released in the simulated intestinal fluid.

Fig 14. Insulin Release vs Time Profile in Simulated Gastric fluid (Blue) and Simulated Intestinal fluid (Red)

Fig 14. Insulin Release vs Time Profile in Simulated Gastric fluid (Blue) and Simulated Intestinal

fluid (Red)

Figure 15 Chromatogram of Humulin N in simulated intestinal fluid

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Figure 16 Standard milk (left) and milk containing insulin loaded nanoparticles (right)

In order to study if there are any differences in the physical properties of the control (milk without

nanoparticles) and the product (milk containing the insulin loaded nanoparticles), a sensory analysis of

appearance (whiteness), aroma and the consistency was conducted on a 9 point hedonic scale from 20

panel members . The results of the sensory analyses of appearance, aroma and consistency are as

represented in figure 17.

Figure 17 Sensory Analysis of Standard milk and Product (Milk Containing Insulin loaded nanoparticle

The nutritional profiles of the milk without and with the nanoparticles are as shown in Figure18 and Figure

19 respectively. From the results of the nutritional analysis studies, it was observed that there is no

significant difference in the total fat, ash and moisture content between the control and the product. A

difference of 0.2g in protein per 100 mL of milk was observed. The product showed 0.2 g increase in

protein compared to the control.

Figure 18 Nutritional Profile of Control (standard milk)

Volume 111 | Issue 7-9 |

Figure 16 Staandard milk (left) and milk containing insulin loaded nanoparticles (right)

In order to study if there are any differences in the physical properties of the control (milk without

nanoparticles) and the product (milk containing the insulin loaded nanoparticles), a sensory analysis of

appearance (whiteness), aroma and the consistency was conducted on a 9 point hedonic scale from 20

panel members . The results of the sensory analyses of appearance, aroma and consistency are as

represented in figure 17.

Figure 17 Sensory Analysis of Standard milk and Product (Milk Containing Insulin loaded nanoparrticle

The nutritional profiles of the milk without and with the nanoparticles are as shown in Figure18 and Figure

19 respectively. From the results of the nutritional analysis studies, it was observed that there is no

significant difference in the total fat, ash and moisture content between the control and the product. A

difference of 0.2g in protein per 100 mL of milk was observed. The product showed 0.2 g increase in

protein compared to the control.

Figure 18 Nutritional Profile of Control (standard milk)

Volume 111 | Issue 7-9 |

The insulin loaded nanoparticles which were investigated for their release characteristics were

synthesized again and were lyophilized. The lyophilized nanoparticles were then added to 4.5% fat

standard milk and mixed thoroughly for few seconds using a blender. There were no settling or

sedimentation of the nanoparticles in the milk. The milk containing Insulin loaded nanoparticles are as

shown in the figure 16.

CONCLUSION

The study concludes that nanoparticles synthesized

with an initial concentration of 0.05% formed

nanofiber-like structures, while those with 0.07%

and 0.09% concentrations showed agglomeration in

scanning electron micrographs. FTIR analysis revealed

well-established interactions between the components

across all three nanoparticle variants. Additionally,

the crystalline nature of the components diminished

or was completely disrupted upon nanoparticle

formation. Due to the relatively low insulin association

efficiency within the nanoparticles synthesized through

this method, further studies, such as in vitro release

Figure 16 Standard milk (left) and milk containing insulin loaded nanoparticles (right)

Figure 17. Sensory Analysis of Standard milk and Product (Milk Containing Insulin loaded

nanoparticle

Figure 18 Nutritional Profile of Control (standard milk)

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Volume 111 | Issue 7-9 |

Figure 19 Nutritional Profile of the Product (Milk containing Insulin loaded nanoparticles)

This may be due to the release of insulin which are held on the surfaces of the coating material by weak

interactions. Further investigations are needed to be made in the development of a method for estimating

the presence and the amount of insulin present in the milk samples.

CONCLUSION

The study concludes that nanoparticles synthesized with an initial concentration of 0.05% formed

nanofiber-like structures, while those with 0.07% and 0.09% concentrations showed agglomeration in

scanning electron micrographs. FTIR analysis revealed well-established interactions between the

components across all three nanoparticle variants. Additionally, the crystalline nature of the components

diminished or was completely disrupted upon nanoparticle formation. Due to the relatively low insulin

association efficiency within the nanoparticles synthesized through this method, further studies, such as in

vitro release testing, were not pursued. The Isophane insulin-loaded nanoparticles were subsequently

mixed with milk to produce the final product, which underwent nutritional analysis. This analysis indicated

an increase in protein content compared to the control sample. Sensory evaluations of color, aroma, and

consistency were conducted on both the product and the control, with results showing no significant

differences, suggesting that the inclusion of insulin-loaded nanoparticles did not impact these attributes.

Based on this study, it is concluded that the product containing insulin-loaded nanoparticles demonstrates

effective insulin release characteristics and exhibits no notable differences in nutritional or sensory

attributes, such as aroma, appearance, and consistency, when compared to standard milk.

REFERENCES

testing, were not pursued. The Isophane insulin-loaded

nanoparticles were subsequently mixed with milk to

produce the final product, which underwent nutritional

analysis. This analysis indicated an increase in protein

content compared to the control sample. Sensory

evaluations of color, aroma, and consistency were

conducted on both the product and the control, with

results showing no significant differences, suggesting

that the inclusion of insulin-loaded nanoparticles did

not impact these attributes. Based on this study, it is

concluded that the product containing insulin-loaded

nanoparticles demonstrates effective insulin release

characteristics and exhibits no notable differences

in nutritional or sensory attributes, such as aroma,

appearance, and consistency, when compared to

standard milk.

REFERENCES

ABD EL SALAM, M. H., S. El Shibiny. 2012. Formation and

potential uses of milk proteins as nano delivery

vehicles for nutraceuticals: a review. International

journal of dairy technology, 65(1), 13-21. https://

doi.org/10.1111/j.1471-0307.2011.00737.x

Elsayed, A., M. Al-Remawi, N. Qinna, A. Farouk, K.A.

Al-Sou’od, and A.A. Badwan. 2011. Chitosan–

sodium lauryl sulfate nanoparticles as a carrier

system for the in vivo delivery of oral insulin.

Aaps Pharmscitech, 12, 958-964. https://doi.

org/10.1208/s12249-011-9647-5

Finotelli, P. V., D. Da Silva, M. Sola-Penna, A.M. Rossi,

M. Farina, L.R. Andrade, ... andM.H. Rocha-

Leão. 2010. Microcapsules of alginate/chitosan

containing magnetic nanoparticles for controlled

release of insulin. Colloids and Surfaces B:

Biointerfaces,

81(1),

206-211.

https://doi.

org/10.1016/j.colsurfb.2010.07.008

Hussain, N., V. Jaitley, and A.T. Florence. 2001. Recent

advances in the understanding of uptake of

microparticulates across the gastrointestinal

lymphatics. Advanced drug delivery reviews,

50(1-2), 107-142. https://doi.org/10.1016/S0169-

409X(01)00152-1

Li, P., Y.N. Dai, J.P. Zhang, A.Q. Wang, and Q.Wei. 2008.

Chitosan-alginate nanoparticles as a novel drug

delivery system for nifedipine. International

journal of biomedical science: IJBS, 4(3), 221.

PMID: 23675094

Lin, Y. H., F.L. Mi, C.T. Chen, W.C. Chang, S.F. Peng,

H.F. Liang, and H.W. Sung. 2007. Preparation

and

characterization

of

nanoparticles

shelled with chitosan for oral insulin delivery.

Biomacromolecules, 8(1), 146-152. https://pubs.

acs.org/doi/abs/10.1021/bm0607776

Makhlof, A., Y.Tozuka, and H. Takeuchi. 2011. Design

and evaluation of novel pH-sensitive chitosan

nanoparticles for oral insulin delivery. European

journal of pharmaceutical sciences, 42(5), 445-

451. https://doi.org/10.1016/j.ejps.2010.12.007

Mobasseri, M., Shirmohammadi, M., Amiri, T., Vahed,

N., Hosseini Fard, H., & Ghojazadeh, M. 2020.

Prevalence and incidence of type 1 diabetes

in the world: a systematic review and meta-

analysis. Health promotion perspectives, 10(2),

98–115. https://doi.org/10.34172/hpp.2020.18

Panyam, J., V. Labhasetwar. 2003. Biodegradable

nanoparticles for drug and gene delivery to cells

and tissue. Advanced drug delivery reviews,

55(3), 329-347. https://doi.org/10.1016/S0169-

409X(02)00228-4

Figure 19 Nutritional Profile of the Product (Milk containing Insulin loaded nanoparticles)

MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021

111|7-9|

Sarmento, B., A. Ribeiro, F. Veiga, P. Sampaio, R.

Neufeld, and D. Ferreira. 2007. Alginate/

chitosan nanoparticles are effective for oral

insulin delivery. Pharmaceutical research, 24,

2198-2206. https://doi.org/10.1007/s11095-007-

9367-4

Sarmento, B., A.J. Ribeiro, F. Veiga, D.C. Ferreira, and

R. J. Neufeld. 2007. Insulin-loaded nanoparticles

are prepared by alginate ionotropic pre-

gelation followed by chitosan polyelectrolyte

complexation. Journal of nanoscience and

nanotechnology, 7(8), 2833-2841. https://doi.

org/10.1166/jnn.2007.609

Sarmento, B., D. Ferreira, F. Veiga, and A. Ribeiro.

2006.

Characterization

of

insulin-loaded

alginate nanoparticles produced by ionotropic

pre-gelation through DSC and FTIR studies.

Carbohydrate polymers, 66(1), 1-7. https://doi.

org/10.1016/j.carbpol.2006.02.008